These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 9524553)

  • 1. Bis(dialkyl)dithiocarbamato cobalt(III) complexes of bidentate nitrogen mustards: synthesis, reduction chemistry and biological evaluation as hypoxia-selective cytotoxins.
    Ware DC; Palmer HR; Pruijn FB; Anderson RF; Brothers PJ; Denny WA; Wilson WR
    Anticancer Drug Des; 1998 Mar; 13(2):81-103. PubMed ID: 9524553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards.
    Ware DC; Palmer BD; Wilson WR; Denny WA
    J Med Chem; 1993 Jun; 36(13):1839-46. PubMed ID: 8515422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anionic carbonato and oxalato cobalt(III) nitrogen mustard complexes.
    Craig PR; Brothers PJ; Clark GR; Wilson WR; Denny WA; Ware DC
    Dalton Trans; 2004 Feb; (4):611-8. PubMed ID: 15252524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bis-tropolonato derivatives of cobalt(III) complexes of bidentate aliphatic nitrogen mustards as potential hypoxia-selective cytotoxins.
    Ware DC; Palmer HR; Brothers PJ; Rickard CE; Wilson WR; Denny WA
    J Inorg Biochem; 1997 Nov; 68(3):215-24. PubMed ID: 9352654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitro analogues of chlorambucil as potential hypoxia-selective anti-tumour drugs.
    Palmer BD; Wilson WR; Denny WA
    Anticancer Drug Des; 1990 Nov; 5(4):337-49. PubMed ID: 2291774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic routes to mixed-ligand cobalt(III) dithiocarbamato complexes containing imidazole, amine and pyridine donors and the X-ray crystal structure of a cobalt(III) bis(dithiocarbamato) histamine complex.
    Hodgson MC; Brothers PJ; Clark GR; Ware DC
    J Inorg Biochem; 2008 Apr; 102(4):789-97. PubMed ID: 18262652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of stable bidentate transition metal complexes of 1-(chloromethyl)-5-hydroxy-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1H-pyrrolo[3,2-f]quinoline (seco-6-azaCBI-TMI) as hypoxia selective cytotoxins.
    Milbank JB; Stevenson RJ; Ware DC; Chang JY; Tercel M; Ahn GO; Wilson WR; Denny WA
    J Med Chem; 2009 Nov; 52(21):6822-34. PubMed ID: 19821576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
    Palmer BD; Wilson WR; Anderson RF; Boyd M; Denny WA
    J Med Chem; 1996 Jun; 39(13):2518-28. PubMed ID: 8691449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tunability of the M(II)M(III)/M(II)(2) and M(III)(2)/M(II)M(III) (M=Mn, Co) couples in bis-μ-O,O'-carboxylato-μ-OR bridged complexes.
    Seidler-Egdal RK; Johansson FB; Veltzé S; Skou EM; Bond AD; McKenzie CJ
    Dalton Trans; 2011 Apr; 40(13):3336-45. PubMed ID: 21359349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A modular approach toward regulating the secondary coordination sphere of metal ions: differential dioxygen activation assisted by intramolecular hydrogen bonds.
    Lucas RL; Zart MK; Mukherjee J; Sorrell TN; Powell DR; Borovik AS
    J Am Chem Soc; 2006 Dec; 128(48):15476-89. PubMed ID: 17132015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dicobalt II-II, II-III, and III-III complexes as spectroscopic models for dicobalt enzyme active sites.
    Johansson FB; Bond AD; Nielsen UG; Moubaraki B; Murray KS; Berry KJ; Larrabee JA; McKenzie CJ
    Inorg Chem; 2008 Jun; 47(12):5079-92. PubMed ID: 18494467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide.
    Lee HH; Wilson WR; Ferry DM; van Zijl P; Pullen SM; Denny WA
    J Med Chem; 1996 Jun; 39(13):2508-17. PubMed ID: 8691448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectral and redox studies on mixed ligand complexes of cobalt(III) phenanthroline/bipyridyl and benzoylhydrazones, their DNA binding and antimicrobial activity.
    Srinivasan S; Annaraj J; Athappan P
    J Inorg Biochem; 2005 Mar; 99(3):876-82. PubMed ID: 15708809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel iron(III) complexes of tripodal and linear tetradentate bis(phenolate) ligands: close relevance to intradiol-cleaving catechol dioxygenases.
    Velusamy M; Palaniandavar M; Gopalan RS; Kulkarni GU
    Inorg Chem; 2003 Dec; 42(25):8283-93. PubMed ID: 14658880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of some novel CoII and CoIII complexes by tribochemical reactions using KI with some derivatives of thiosemicarbazide complexes derived from Girard's T and P.
    Al-Ashqar SM; Mostafa MM
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Dec; 71(4):1321-6. PubMed ID: 18534903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching on oxygen activation by cobalt complexes of pentadentate ligands.
    Vad MS; Nielsen A; Lennartson A; Bond AD; McGrady JE; McKenzie CJ
    Dalton Trans; 2011 Oct; 40(40):10698-707. PubMed ID: 21866283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study on the properties and reactivity of naphthoquinone-cobalt(III) prototypes for bioreductive prodrugs.
    Bustamante FL; Miranda FS; Castro FA; Resende JA; Pereira MD; Lanznaster M
    J Inorg Biochem; 2014 Mar; 132():37-44. PubMed ID: 24326134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper(I)-dioxygen reactivity of [(L)Cu(I)](+) (L = tris(2-pyridylmethyl)amine): kinetic/thermodynamic and spectroscopic studies concerning the formation of Cu-O2 and Cu2-O2 adducts as a function of solvent medium and 4-pyridyl ligand substituent variations.
    Zhang CX; Kaderli S; Costas M; Kim EI; Neuhold YM; Karlin KD; Zuberbühler AD
    Inorg Chem; 2003 Mar; 42(6):1807-24. PubMed ID: 12639113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-selective antitumor agents. 12. Nitrobenzyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine.
    Tercel M; Wilson WR; Anderson RF; Denny WA
    J Med Chem; 1996 Mar; 39(5):1084-94. PubMed ID: 8676343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives.
    Vieites M; Noblía P; Torre MH; Cerecetto H; Laura Lavaggi M; Costa-Filho AJ; Azqueta A; de Cerain AL; Monge A; Parajón-Costa B; González M; Gambino D
    J Inorg Biochem; 2006 Aug; 100(8):1358-67. PubMed ID: 16698084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.